LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 672

Search options

  1. Article: Jeder Schritt ist besser als keiner. Bewegung bei Bluthochdruck. Interview mit Ulf Landmesser

    Landmesser, Ulf

    Herz heute

    2011  Volume 31, Issue 1-4, Page(s) 11

    Language German
    Document type Article
    ZDB-ID 1474834-4
    ISSN 1437-5176
    Database Current Contents Medicine

    More links

    Kategorien

  2. Article ; Online: The Changing Landscape of Aortic-Valve Stenosis Management.

    Landmesser, Ulf

    The New England journal of medicine

    2023  Volume 389, Issue 21, Page(s) 2008–2009

    MeSH term(s) Humans ; Aortic Valve/diagnostic imaging ; Aortic Valve/surgery ; Aortic Valve Stenosis/surgery ; Constriction, Pathologic ; Heart Valve Prosthesis Implantation
    Language English
    Publishing date 2023-11-19
    Publishing country United States
    Document type Editorial
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMe2311826
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Optical Coherence Tomography-Guided versus Angiography-Guided PCI. Reply.

    Ali, Ziad A / Landmesser, Ulf / Stone, Gregg W

    The New England journal of medicine

    2024  Volume 390, Issue 2, Page(s) 186–187

    MeSH term(s) Humans ; Percutaneous Coronary Intervention ; Tomography, Optical Coherence
    Language English
    Publishing date 2024-01-10
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMc2313256
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: New Chapter in the PCSK9 Book: Oral Inhibition of PCSK9 Binding to the LDL Receptor With a Macrocyclic Peptide.

    Landmesser, Ulf / Makhmudova, Umidakhon

    Circulation

    2023  Volume 148, Issue 2, Page(s) 159–161

    MeSH term(s) Humans ; Proprotein Convertase 9 ; Receptors, LDL/genetics ; Receptors, LDL/metabolism ; Peptides
    Chemical Substances PCSK9 protein, human (EC 3.4.21.-) ; Proprotein Convertase 9 (EC 3.4.21.-) ; Receptors, LDL ; Peptides
    Language English
    Publishing date 2023-07-10
    Publishing country United States
    Document type Editorial
    ZDB-ID 80099-5
    ISSN 1524-4539 ; 0009-7322 ; 0069-4193 ; 0065-8499
    ISSN (online) 1524-4539
    ISSN 0009-7322 ; 0069-4193 ; 0065-8499
    DOI 10.1161/CIRCULATIONAHA.123.065407
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Hypercholesterinämie und kardiovaskuläres Risiko.

    Sinning, David / Landmesser, Ulf

    Deutsche medizinische Wochenschrift (1946)

    2023  Volume 148, Issue 16, Page(s) 1025–1032

    Abstract: Pharmacological reduction of LDL-cholesterol (LDL-C) is a major treatment strategy in limiting atherosclerotic cardiovascular (ASCVD) risk. Statins remain the primary therapeutic cornerstone in ASCVD prevention. Furthermore, ezetimibe, bempedoic acid, ... ...

    Title translation Hypercholesterolemia and cardiovascular risk.
    Abstract Pharmacological reduction of LDL-cholesterol (LDL-C) is a major treatment strategy in limiting atherosclerotic cardiovascular (ASCVD) risk. Statins remain the primary therapeutic cornerstone in ASCVD prevention. Furthermore, ezetimibe, bempedoic acid, and PCSK9 inhibition have recently also shown to reduce cardiovascular risk. Unfortunately, a treatment gap remains between guideline-recommended LDL-C goals and what is achieved in real-world practice. An important reason for this is the limited use of novel and effective non-statin lipid-lowering therapies. In order to achieve LDL-C treatment goals and, ultimately, reduction of cardiovascular events, a combination lipid-lowering therapy needs to be considered as the standard of care for patients at very high cardiovascular risk.
    MeSH term(s) Humans ; Hypercholesterolemia/drug therapy ; Proprotein Convertase 9/therapeutic use ; Cholesterol, LDL ; Anticholesteremic Agents/therapeutic use ; Cardiovascular Diseases/drug therapy ; Risk Factors ; Hyperlipidemias/drug therapy ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Atherosclerosis/drug therapy ; Heart Disease Risk Factors ; Ezetimibe/therapeutic use
    Chemical Substances PCSK9 protein, human (EC 3.4.21.-) ; Proprotein Convertase 9 (EC 3.4.21.-) ; Cholesterol, LDL ; Anticholesteremic Agents ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Ezetimibe (EOR26LQQ24)
    Language German
    Publishing date 2023-08-04
    Publishing country Germany
    Document type English Abstract ; Journal Article
    ZDB-ID 200446-x
    ISSN 1439-4413 ; 0012-0472
    ISSN (online) 1439-4413
    ISSN 0012-0472
    DOI 10.1055/a-1932-6448
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Detection and modification of biomarkers of inflammation determining successful rhythm control in patients with atrial fibrillation.

    Schreiber, Tobias / Grune, Jana / Landmesser, Ulf / Attanasio, Philipp

    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals

    2024  Volume 28, Issue 8, Page(s) 681–691

    Abstract: Introduction: Multiple pathophysiological mechanisms are involved in the pathogenesis of atrial fibrillation (AF). Growing evidence suggests that both local and systemic inflammation plays a key role even in early stages and its progression towards ... ...

    Abstract Introduction: Multiple pathophysiological mechanisms are involved in the pathogenesis of atrial fibrillation (AF). Growing evidence suggests that both local and systemic inflammation plays a key role even in early stages and its progression towards persisting and permanent AF. Rhythm control therapy via pulmonary vein isolation or cardioversion is the cornerstone of AF therapy for most symptomatic patients, yet arrhythmia recurrence after treatment is still common, especially in patients with persistent AF.
    Material and methods: In this review, we summarize the current state of knowledge of biomarkers of inflammation with prognostic value in patients with atrial fibrillation as well as anti-inflammatory medication with potential benefits after rhythm control therapy.
    Results and discussion: Both onset of AF, progression and arrhythmia recurrence after rhythm control therapy can be caused by local and systemic inflammation. Various inflammatory biomarkers have been established to predict treatment success. Furthermore, additional anti-inflammatory therapy may significantly improve success rates.
    MeSH term(s) Humans ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/drug therapy ; Treatment Outcome ; Inflammation/complications ; Biomarkers ; Anti-Inflammatory Agents ; Catheter Ablation/adverse effects ; Recurrence
    Chemical Substances Biomarkers ; Anti-Inflammatory Agents
    Language English
    Publishing date 2024-01-22
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1324372-x
    ISSN 1366-5804 ; 1354-750X
    ISSN (online) 1366-5804
    ISSN 1354-750X
    DOI 10.1080/1354750X.2023.2284122
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Reply to Letter: Potential problems with concomitant therapy with Impella® and veno-arterial extracorporeal membrane oxygenation in patients with cardiac arrest.

    Thevathasan, Tharusan / Landmesser, Ulf / Skurk, Carsten

    Resuscitation

    2023  Volume 190, Page(s) 109915

    MeSH term(s) Humans ; Extracorporeal Membrane Oxygenation ; Shock, Cardiogenic/therapy ; Heart Arrest/therapy
    Language English
    Publishing date 2023-07-26
    Publishing country Ireland
    Document type Letter ; Comment
    ZDB-ID 189901-6
    ISSN 1873-1570 ; 0300-9572
    ISSN (online) 1873-1570
    ISSN 0300-9572
    DOI 10.1016/j.resuscitation.2023.109915
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Hypercholesterinämie und kardiovaskuläres Risiko

    Sinning, David / Landmesser, Ulf

    DMW - Deutsche Medizinische Wochenschrift

    2023  Volume 148, Issue 16, Page(s) 1025–1032

    Keywords Hypercholesterinämie ; kardiovaskulär ; Risiko ; LDL-Cholesterin ; hypercholesterolemia ; cardiovascular ; risk ; LDL-cholesterol
    Language German
    Publishing date 2023-08-01
    Publisher Georg Thieme Verlag KG
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 200446-x
    ISSN 1439-4413 ; 0012-0472
    ISSN (online) 1439-4413
    ISSN 0012-0472
    DOI 10.1055/a-1932-6448
    Database Thieme publisher's database

    More links

    Kategorien

  9. Article ; Online: Understanding Who Responds to M-TEER in Heart Failure With SMR: Malnutrition Does Not Preclude Benefit.

    Anker, Markus S / von Haehling, Stephan / Landmesser, Ulf

    Journal of the American College of Cardiology

    2023  Volume 82, Issue 2, Page(s) 139–141

    MeSH term(s) Humans ; Heart Failure/complications ; Heart Failure/therapy ; Malnutrition/complications ; Mitral Valve Insufficiency ; Treatment Outcome ; Heart Valve Prosthesis Implantation
    Language English
    Publishing date 2023-05-20
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 605507-2
    ISSN 1558-3597 ; 0735-1097
    ISSN (online) 1558-3597
    ISSN 0735-1097
    DOI 10.1016/j.jacc.2023.05.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: PCSK9 inhibition and clinical cardiovascular outcomes in patients with atherosclerotic cardiovascular disease.

    Landmesser, Ulf

    Cardiovascular research

    2017  Volume 113, Issue 8, Page(s) e24–e25

    MeSH term(s) Antibodies, Monoclonal ; Cardiovascular Diseases ; Humans ; Proprotein Convertase 9
    Chemical Substances Antibodies, Monoclonal ; PCSK9 protein, human (EC 3.4.21.-) ; Proprotein Convertase 9 (EC 3.4.21.-) ; evolocumab (LKC0U3A8NJ)
    Language English
    Publishing date 2017-09-01
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 80340-6
    ISSN 1755-3245 ; 0008-6363
    ISSN (online) 1755-3245
    ISSN 0008-6363
    DOI 10.1093/cvr/cvx109
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top